Johnson & Johnson EBITDA Margin 2012-2026 | JNJ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Johnson & Johnson (JNJ) over the last 10 years. The current EBITDA margin for Johnson & Johnson as of March 31, 2026 is
Unlock Macrotrends Premium
Start 7-Day Free Trial
Johnson & Johnson EBITDA Margin Historical Data
Date
TTM Revenue
TTM EBITDA
EBITDA Margin
2025-12-31
$94.19B
$42.11B
44.71%
2025-09-30
$92.15B
$40.88B
44.37%
2025-06-30
$90.63B
$36.81B
40.62%
2025-03-31
$89.33B
$36.00B
40.30%
2024-12-31
$88.82B
$26.11B
29.40%
2024-09-30
$87.70B
$27.10B
30.90%
2024-06-30
$86.58B
$29.04B
33.54%
2024-03-31
$85.65B
$29.63B
34.59%
2023-12-31
$85.16B
$24.58B
28.86%
2023-09-30
$76.31B
$22.09B
28.94%
2023-06-30
$74.96B
$21.53B
28.73%
2023-03-31
$77.46B
$20.44B
26.38%
2022-12-31
$79.99B
$27.10B
33.87%
2022-09-30
$77.21B
$25.56B
33.11%
2022-06-30
$80.55B
$24.20B
30.04%
2022-03-31
$79.85B
$25.07B
31.39%
2021-12-31
$78.74B
$26.80B
34.04%
2021-09-30
$91.45B
$27.34B
29.89%
2021-06-30
$89.19B
$27.92B
31.30%
2021-03-31
$84.21B
$25.09B
29.80%
2020-12-31
$82.58B
$24.04B
29.11%
2020-09-30
$80.86B
$26.55B
32.84%
2020-06-30
$80.50B
$23.79B
29.55%
2020-03-31
$82.73B
$26.98B
32.61%
2019-12-31
$82.06B
$25.01B
30.48%
2019-09-30
$81.71B
$24.12B
29.51%
2019-06-30
$81.33B
$27.18B
33.42%
2019-03-31
$81.59B
$25.33B
31.04%
2018-12-31
$81.58B
$26.54B
32.54%
2018-09-30
$81.38B
$26.03B
31.98%
2018-06-30
$80.68B
$26.26B
32.55%
2018-03-31
$78.69B
$25.42B
32.31%
2017-12-31
$76.45B
$24.63B
32.22%
2017-09-30
$74.36B
$25.51B
34.30%
2017-06-30
$72.53B
$25.18B
34.72%
2017-03-31
$72.17B
$25.04B
34.69%
2016-12-31
$71.89B
$24.65B
34.29%
2016-09-30
$71.60B
$23.99B
33.51%
2016-06-30
$70.88B
$22.72B
32.06%
2016-03-31
$70.18B
$23.42B
33.37%
2015-12-31
$70.07B
$23.62B
33.71%
2015-09-30
$70.52B
$22.47B
31.86%
2015-06-30
$71.88B
$25.16B
35.00%
2015-03-31
$73.59B
$25.09B
34.10%
2014-12-31
$74.33B
$25.06B
33.71%
2014-09-30
$74.43B
$25.21B
33.87%
2014-06-30
$73.54B
$22.08B
30.03%
2014-03-31
$71.92B
$21.28B
29.59%
2013-12-31
$71.31B
$20.13B
28.23%
2013-09-30
$70.52B
$20.39B
28.91%
2013-06-30
$69.99B
$20.37B
29.11%
2013-03-31
$68.59B
$17.50B
25.51%
2012-12-31
$67.22B
$18.04B
26.83%
2012-09-30
$65.92B
$15.16B
22.99%
2012-06-30
$64.87B
$15.45B
23.82%
2012-03-31
$65.00B
$16.75B
25.77%
2011-12-31
$65.03B
$16.18B
24.88%
2011-09-30
$64.42B
$17.96B
27.88%
2011-06-30
$63.40B
$17.98B
28.36%
2011-03-31
$62.13B
$18.71B
30.11%
2010-12-31
$61.59B
$20.45B
33.20%
2010-09-30
$62.49B
$20.74B
33.19%
2010-06-30
$62.59B
$20.77B
33.18%
2010-03-31
$62.50B
$20.77B
33.23%
2009-12-31
$61.90B
$19.07B
30.81%
2009-09-30
$60.53B
$20.05B
33.13%
2009-06-30
$61.37B
$20.24B
32.98%
2009-03-31
$62.58B
$20.41B
32.62%
2008-12-31
$63.75B
$20.56B
32.25%
2008-09-30
$64.52B
$19.55B
30.30%
2008-06-30
$63.57B
$18.35B
28.87%
2008-03-31
$62.25B
$17.97B
28.87%
2007-12-31
$61.10B
$16.81B
27.51%
2007-09-30
$58.82B
$16.90B
28.72%
2007-06-30
$57.14B
$17.24B
30.16%
2007-03-31
$55.37B
$16.74B
30.23%
2006-12-31
$53.32B
$17.66B
33.11%
2006-09-30
$52.25B
$17.32B
33.15%
2006-06-30
$51.28B
$16.99B
33.14%
2006-03-31
$50.67B
$16.56B
32.68%
2005-12-31
$50.51B
$15.75B
31.18%
2005-09-30
$50.66B
$15.44B
30.47%
2005-06-30
$49.90B
$15.18B
30.42%
2005-03-31
$48.62B
$15.29B
31.44%
2004-12-31
$47.35B
$14.84B
31.34%
2004-09-30
$45.85B
$14.94B
32.59%
2004-06-30
$44.75B
$14.68B
32.79%
2004-03-31
$43.60B
$13.20B
30.28%
2003-12-31
$41.86B
$12.56B
30.01%
2003-09-30
$40.01B
$11.92B
29.80%
2003-06-30
$38.64B
$11.28B
29.20%
2003-03-31
$37.38B
$11.68B
31.24%
2002-12-31
$36.30B
$11.37B
31.32%
2002-09-30
$35.12B
$10.98B
31.26%
2002-06-30
$34.10B
$10.74B
31.51%
2002-03-31
$33.21B
$10.47B
31.53%
2001-12-31
$32.32B
$10.11B
31.29%
2001-09-30
$31.20B
$9.79B
31.38%
2001-06-30
$30.58B
$9.51B
31.10%
2001-03-31
$30.07B
$9.28B
30.84%
2000-12-31
$29.54B
$8.93B
30.25%
2000-09-30
$29.30B
$8.38B
28.60%
2000-06-30
$28.75B
$8.02B
27.91%
2000-03-31
$28.05B
$7.65B
27.26%
1999-12-31
$27.47B
$7.37B
26.83%
1999-09-30
$27.06B
$7.68B
28.37%
1999-06-30
$25.99B
$7.31B
28.13%
1999-03-31
$24.89B
$6.98B
28.02%
1998-12-31
$24.00B
$6.57B
27.38%
1998-09-30
$23.16B
$6.23B
26.89%
1998-06-30
$22.93B
$6.03B
26.31%
1998-03-31
$22.75B
$5.85B
25.69%
1997-12-31
$22.63B
$5.69B
25.14%
1997-09-30
$22.50B
$9.80B
43.55%
1997-06-30
$22.32B
$9.76B
43.73%
1997-03-31
$22.00B
$5.48B
24.93%
1996-12-31
$21.62B
$5.31B
24.57%
1996-09-30
$20.96B
$0.79B
3.79%
1996-06-30
$20.30B
$0.29B
1.41%
1996-03-31
$19.68B
$3.97B
20.17%
1995-12-31
$18.84B
$3.51B
18.63%
1995-09-30
$18.09B
$3.43B
18.99%
1995-06-30
$17.39B
$3.25B
18.68%
1995-03-31
$16.54B
$3.04B
18.40%
1994-12-31
$14.97B
$2.05B
13.66%
1994-09-30
$14.41B
$1.94B
13.43%
1994-06-30
$13.88B
$1.78B
12.79%
1994-03-31
$13.51B
$1.69B
12.53%
1993-12-31
$14.14B
$2.39B
16.93%
1993-09-30
$14.11B
$2.35B
16.63%
1993-06-30
$14.08B
$2.34B
16.63%
1993-03-31
$13.96B
$2.32B
16.65%
1992-12-31
$13.75B
$2.28B
16.56%
1992-09-30
$13.40B
$2.31B
17.20%
1992-06-30
$13.04B
$2.24B
17.18%
1992-03-31
$12.66B
$2.18B
17.19%
1991-12-31
$12.45B
$2.16B
17.39%
1991-09-30
$12.00B
$2.08B
17.30%
1991-06-30
$11.75B
$2.03B
17.28%
1991-03-31
$11.54B
$1.96B
16.96%
1990-12-31
$11.23B
$1.99B
17.74%
1990-09-30
$11.00B
$1.98B
17.97%
1990-06-30
$10.59B
$1.92B
18.18%
1990-03-31
$10.15B
$1.85B
18.18%
1989-12-31
$9.76B
$1.66B
17.02%
1989-09-30
$9.49B
$1.56B
16.49%
1989-06-30
$9.23B
$1.49B
16.10%
1989-03-31
$9.13B
$1.46B
15.93%
1988-12-31
$9.00B
$1.40B
15.60%
1988-09-30
$8.73B
$1.30B
14.89%
1988-06-30
$8.57B
$1.30B
15.18%
1988-03-31
$8.34B
$1.30B
15.60%
1987-12-31
$8.01B
$1.21B
15.09%
Sector
Industry
Market Cap
Revenue
Medical Large Cap Pharmaceutical $574.358B
$94.193B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
